本研究利用丙烯酸(Acrylic acid, AA)與氮-異丙基丙烯醯胺 (N-isopropylamide, NIPAAm)以可逆加成-斷裂鏈轉移聚合(Reversible addition- fragmentation chain transfer polymerization,RAFT)活性自由基聚合方法合成出具環境應答性質的嵌段共聚物PAA-b-PNP,利用紅外線光譜儀(FTIR)及核磁共振光譜儀(1H-NMR)對產物作結構鑑定,分別求出共聚物的AA和NIPAAm的聚合度、轉化率及分子量。調整反應時間可使AA和NIPAAm的單體轉化率都可達到100%,並讓具有溫度及 pH 值雙重敏感性的PAA-b-PNP微胞複合載體,加入幾丁聚醣增加其生物相容性,得到具有溫度及 pH 值雙重敏感性質之PAA-b-PNP/CS奈米藥物載體(50~400 nm)。利用此藥物載體包覆疏水性藥物喜樹鹼(Camptothecin,CPT),藥物包覆率(Encapsulation efficiency, EE)及 、藥物負載率(Loading capacity, LC)會根據不同的PAA-b-PNP/CS組成而有變化。最後本研究發現PAA-b-PNP/CPT/CS奈米顆粒於強酸環境下可以穩定的存在,而在人體體液(pH = 7.4)的環境下,其奈米水膠顆粒會不穩定而膨潤或是瓦解,PAA-b-PNP/CPT/CS奈米藥物載體可適用於口服藥物之遞送系統,亦即在胃酸(pH 2.0)裡面不會讓藥物釋出,並保護藥物不會在強酸環境下被破壞,最後可以在小腸(pH = 7.4)的環境下快速釋放藥物。
In this study, acrylic acid (Arylic acid, AA) and N-isopropylamide (NIPAAm) were polymerized to prepare environmentally-responsive block copolymers using reversible addition-fragmentation chain transfer polymerization (RAFT) living radical polymerization. Structure of the prepared PAA-b-PNP block copolymers was identified by infrared spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (1H-NMR), as well as the polymerization, degree of conversion and molecular weight. Both monomer conversions of AA and NIPAAm could reach 100%. Furthermore, chitosan was added to PAA-b-PNP gel particals above its LCST to prepare environmentally-sensitive PAA-b-PNP/CS nano drug carrier (50~400 nm). For increasing biocompatibility, a hydrophobic drug camptothecin (CPT) was then encapsulated into the drug carrier, and the encapsulation efficiency (EE) the loading capacity (LC) according to different were varied formulations in PAA-b-PNP/CS. Finally, this study found that PAA-b-PNP/CPT/CS nanoparticles be stably present in a strong acid environment, while in the body fluid (pH = 7.4), the nano gel particles became unstable and swoiien or Is disintegrated, Therefore, PAA-b-PNP/CPT/CS nano drug carrier can be applied to the oral drug delivery system.The nano drug carrier would not allow the drug to be released in the stomach (pH 2.0), protecting the drug from being released in a strong acid environment. The drug would be finally released the drug rapidly in the environment of the small intestine (pH = 7.4).